Claude Nicaise - Net Worth and Insider Trading

Over the past 18 months, Claude Nicaise made no insider transaction in Sarepta Therapeutics Inc (SRPT). Other recent insider transactions involving Sarepta Therapeutics Inc (SRPT) include a net purchase of 68,532 shares made by Michael Andrew Chambers , a net sale of 30,000 shares made by Wigzell Hans Lennart Rudolf , and a net purchase of 50,000 shares made by Richard Barry .

In summary, during the past 3 months, insiders sold 19,396 shares of Sarepta Therapeutics Inc (SRPT) in total and bought 0 shares, with a net sale of 19,396 shares. During the past 18 months, 42,731 shares of Sarepta Therapeutics Inc (SRPT) were sold and 143,757 shares were bought by its insiders, resulting in a net purchase of 101,026 shares.

Sarepta Therapeutics Inc (SRPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Claude Nicaise made no insider transaction in Chemomab Therapeutics Ltd (CMMB). Other recent insider transactions involving Chemomab Therapeutics Ltd (CMMB) include a net sale of 336,900 shares made by Orbimed Israel Biofund Gp Limited Partnership ,

In summary, during the past 3 months, insiders sold 0 shares of Chemomab Therapeutics Ltd (CMMB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 336,900 shares of Chemomab Therapeutics Ltd (CMMB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 336,900 shares.

Chemomab Therapeutics Ltd (CMMB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Claude Nicaise made no insider transaction in Gain Therapeutics Inc (GANX). Other recent insider transactions involving Gain Therapeutics Inc (GANX) include a net sale of 2,026 shares made by Matthias Alder , and a net purchase of 30,000 shares made by Jeffrey Scott Riley .

In summary, during the past 3 months, insiders sold 0 shares of Gain Therapeutics Inc (GANX) in total and bought 30,000 shares, with a net purchase of 30,000 shares. During the past 18 months, 2,026 shares of Gain Therapeutics Inc (GANX) were sold and 30,000 shares were bought by its insiders, resulting in a net purchase of 27,974 shares.

Gain Therapeutics Inc (GANX)'s detailed insider trading history can be found in Insider Trading Tracker table.